Journey Medical (DERM)

• Market cap: $215M
• 1 day: 2.06%
• 5 days: 2.06%
• 1 month: -0.38%
• 3 months: 8.94%
• 6 months: 24.72%
• Year to date: 98%
• 1 year: 68.15%
• 5 years: -16.63%
• 10 years: -16.63%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Employees: 41